| Cancer |
|
" Do not follow where the path may lead. Go instead where there is no path and leave a trail." Ralph Waldo Emerson | |
![]() |
|


















| Cancer | ALLIANCES Slide presentation produced jointly by Mediscience Technologies and Sarnoff Corporation click here Sarnoff Corporation web site (www.sarnoff.com) click here MEDISCIENCE TECHNOLOGY, SARNOFF CORPORATION TO JOINTLY DEVELOP OPTICALLY-BASED DIAGNOSTIC PRODUCTS Cherry Hill, NJ (September 12, 2000) - Mediscience Technology Corp. (OTC BB "MDSC") of Cherry Hill and Sarnoff Corporation of Princeton, NJ, today announced a technical and financial agreement under which they plan to merge their respective intellectual property to develop and commercialize optical technology products to address multiple diagnostic applications.The products will use a new and more sensitive approach to early cancer detection and physiological functional diagnostics. Their potential applications include cancer screening for organs such as the cervix, the aerodigestive system, the GI tract, and the lungs, where the tissue surface is subject to optical interrogation either directly or through the use of fiber optics. They will be based on proprietary non-invasive photonics-fluorescence technology under development by Mediscience Technology Corporation. Under the plan announced today Sarnoff will take an initial equity position in Mediscience, with increases in the equity share possible at milestones during the development and commercialization process. In return Sarnoff will provide exclusive licenses to its intellectual property, plus related engineering expertise. "It is estimated that the potential U.S. market for this technology is in excess of $1 billion, and the world market in excess of $2.5 billion," said the President and CEO of Mediscience. "We expect our joint effort with Sarnoff to yield the commitments necessary to fund design and product platform development, the current on-going clinical trials, and operating overhead. This agreement will also help accelerate product commercialization by building upon proprietary intellectual property from both companies." Sarnoff Corporation is a world leader in light sources, imaging systems and related software. Founded in 1942 as RCA Laboratories, its decades of innovation include the development of color television and the liquid-crystal display, and a leadership role in creating the present digital and HDTV standard for the U.S. As an equity participant, Sarnoff's corporate strategy will be focused on actively assisting Mediscience in realizing the significant market potential of the planned diagnostic products. |